Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05604664

Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc

Conditions: Esophageal Cancer

Sex: All
Enrollment: 1727
Sponsor: Yongtao Han

Location: China

Summary

The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question[s] it aims to answer is:provide a basis for accurate staging and the relationship between OS and lymph node dissection

Eligibility Criteria

Inclusion Criteria:Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0)Underwent esophagecomy (two-field or three-field LN dissection)The primary tumor was thoracic ESCCExclusion Criteria:Located outside the thoracicPatients underwent salvage or R1/R2 esophagecomyThe number of resected lymph nodes (RLNs) less than 15With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05604664). StuddyBuddy aggregates publicly available trial information.